Seeking for Perfected Aortic Arch Reconstruction Using a Graphically Designed Patient-specific Surgical Patch
Launched by THE HOSPITAL FOR SICK CHILDREN · Feb 24, 2025
Trial Information
Current as of July 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to perform surgery on newborns with a serious heart condition called Hypoplastic Left Heart Syndrome (HLHS), which includes a problem known as aortic arch hypoplasia. The goal is to create a special, custom-designed patch that can help reconstruct the aortic arch, allowing normal blood flow as the baby grows. By using advanced technology like 3D printing, doctors can create models of the heart and test different patch designs to find the best solution for each patient. This approach aims to make the surgery easier and more successful, ultimately improving the outcomes for these young patients.
To be eligible for this trial, babies aged 0 to 2 months who need a specific type of heart surgery called the Norwood procedure can participate, provided their parents give consent. The study will involve creating personalized patches based on detailed tests and imaging, and researchers will follow the babies as they grow to see how well the repairs are working. This innovative trial is not yet recruiting participants, but it offers hope for better surgical options for infants with complex heart conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Newborns, 0-2 months of age
- • Requiring a Norwood procedure and aortic arch reconstruction
- • Consent provided
- Exclusion Criteria:
- • Consent not provided
- • Contraindications to contrast CT scans (allergy to contrast, kidney disease)
- • Any condition or diagnosis, that could in the opinion of the Principal Investigator or delegate interfere with the participant's ability to comply with the study, might confound the interpretation of the study results, or put the participant at risk
About The Hospital For Sick Children
The Hospital for Sick Children (SickKids) is a leading pediatric health care and research institution located in Toronto, Canada. With a commitment to advancing child health through innovative research, education, and clinical care, SickKids is recognized globally for its expertise in pediatric medicine. The hospital actively sponsors clinical trials aimed at improving treatment outcomes and enhancing the quality of life for children with various health conditions. By fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities, SickKids strives to translate research findings into tangible advancements in pediatric care, ensuring that children receive the best possible treatments based on the latest scientific evidence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported